14 results · 22ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Ceramic Bracket

FDA 510(k)
FDA Class 2 ·Dental

OLYMPUS EMPOWER H65

FDA Adverse Event
Malfunction ·QUANTA SYSTEM S.P.A.·Product code GEX·May 19, 2022

MODIFICATION TO SYNTHES MATRIX SYSTEM

FDA 510(k)
FDA Class 2 ·Orthopedic

15-INCH (38 CM) COLOR LCD MONITOR CDL1576A

FDA 510(k)
FDA Class 2 ·Radiology

G4 PLATINUM CONTINUOUS GLUCOSE MONITORING SYSTEM

FDA Adverse Event
Malfunction ·DEXCOM, INC.·Product code MDS·October 17, 2014

ONETOUCHPING GLUCOSEMGMTSYSTEM

FDA Adverse Event
Malfunction ·ANIMAS CORPORATION·Product code LZG·June 20, 2013

PULSE GEN MODEL 102

FDA Adverse Event
Injury ·CYBERONICS, INC.·Product code LYJ·July 22, 2011

MODIFIED NOVY CORNUAL CANNULATION SET

FDA Adverse Event
Malfunction ·COOK INC·Product code MOV·March 14, 2024

ORTHOSIS, SPINAL PEDICLE FIXATION, FOR DDD

FDA Adverse Event
Injury ·SYNTHES USA·Product code NKB·January 18, 2016

PEDICSCR MATRIX 5.5 POLYAXIAL Ø6 PREASSM

FDA Adverse Event
Malfunction ·SYNTHES GMBH·Product code HWC·June 7, 2013

MODIFIED NOVY CORNUAL CANNULATION SET

FDA Adverse Event
Malfunction ·COOK INC·Product code MOV·January 10, 2024

MODIFIED NOVY CORNUAL CANNULATION SET

FDA Adverse Event
Malfunction ·COOK INC·Product code MOV·November 22, 2024

5.5MM TI CURVED ROD 45MM

FDA Adverse Event
Injury ·OBERDORF SYNTHES PRODUKTIONS GMBH·Product code NKB·February 6, 2020

Merlin PCS Programmer software model 3330, used with Confirm Rx Insertable Cardiac Monitor (ICM), Model DM3500, Sterile. The firm name on the label of the ICM is St. Jude Medical Cardiac Rhythm Management Division, Sylmar, CA. - Product Usage: The Confirm Rx insertable cardiac monitor is designed to detect arrhythmias and wirelessly transmit data to the Merlin.net Patient Care Network. The Confirm Rx ICM is indicated for the monitoring and diagnostic evaluation of patients who experience unexplained symptoms such as: dizziness, palpitations, chest pain, syncope, and shortness of breath, as well as patients who are at risk for cardiac arrhythmias. It is also indicated for patients who have been previously diagnosed with atrial fibrillation or who are susceptible to developing atrial fibrillation.

FDA Enforcement
Class II ·Terminated·St Jude Medical, Cardiac Rhythm Management Division·January 22, 2020